Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study

OBJECTIVE: To report long‐term post hoc efficacy and safety data from 10 US study sites from an open‐label Phase 3 study of adjunctive cenobamate (NCT02535091). METHODS: Patients with uncontrolled focal seizures taking stable doses of 1–3 antiseizure medications (ASMs) were administered increasing d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sperling, Michael R., Abou‐Khalil, Bassel, Aboumatar, Sami, Bhatia, Perminder, Biton, Victor, Klein, Pavel, Krauss, Gregory L., Vossler, David G., Wechsler, Robert, Ferrari, Louis, Grall, Mindy, Rosenfeld, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293007/
https://www.ncbi.nlm.nih.gov/pubmed/34633084
http://dx.doi.org/10.1111/epi.17091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293007/
https://www.ncbi.nlm.nih.gov/pubmed/34633084
http://dx.doi.org/10.1111/epi.17091

Ejemplares similares